Verastem Inc.

$VSTM is down big today following the release of new clinical trial data for its metastatic pancreatic cancer treatment. Apparently nearly half of the participants suffered from serious adverse events.

Share This Article

 

About the Author

Verastem Inc.

Joey Ramson